Toripalimab,Oxaliplatin,Capecitabine,Tegafur,gimeracil,oteracil
Coherus,Junshi Biosciences,nordic group,otsuka
['toripalimab']
 peri-op toripalimab + sox/xelox vs sox/xelox for gc/ gej #asco23 phs-2, 108 pts, ep: trg 0/1 rate trg 0/1: 44% vs 20% pcr: 24.1% vs 9.3% ypt0-2: 46.3% vs 22.2% pdl1 expression? promising activity! 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology